# Current cancer drug targets

Source: https://onco.cc/journals/current-cancer-drug-targets/  
OnCo record `current-cancer-drug-targets` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Current Cancer Drug Targets is a Bentham Science journal on molecular targets for cancer drugs and the agents aimed at them. Pharmacologists and translational cancer researchers read it for reviews and research on targeted therapy.

## Summary

Current Cancer Drug Targets is published by Bentham Science Publishers and, according to its publisher pages, supports open access alongside subscription publication, issues thematic issues alongside general articles, and is indexed in Scopus, Science Citation Index Expanded and MEDLINE/PubMed. The publisher notes that from September 2024 submissions are handled through a new submission system. NLM records the title from 2001, published by Bentham Science Publishers in Hilversum, the Netherlands, and Boca Raton, Florida, eleven issues a year since 2019, and indexed in MEDLINE and PubMed. Crossref lists Bentham Science Publishers Ltd. for both ISSNs. The journal is not listed in DOAJ.

## Fields

- Kind: Journal
- Last checked: 2026-09-10
- Also known as: Curr Cancer Drug Targets; Current Cancer Drug Targets
- Publisher: Bentham Science Publishers
- Scope: cancer pharmacology and drug targets
- Access: hybrid

## Sources

- Homepage: https://www.eurekaselect.com/journal/7
- NLM Catalog: https://www.ncbi.nlm.nih.gov/nlmcatalog/101094211

## Connected records

- collections: [PubMed & Europe PMC](https://onco.cc/collections/pubmed-europepmc/)
- fronts: [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/), [Targeted Therapy](https://onco.cc/fronts/targeted-therapy/)
- people: [Pia Vihinen](https://onco.cc/people/pia-vihinen/)

---
JSON: https://onco.cc/api/v1/entities/current-cancer-drug-targets.json